These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21284752

  • 21. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G.
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [Abstract] [Full Text] [Related]

  • 22. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E, Gonzalo I, Newell K, García Yébenes J, Vonsattel P, Hyman BT.
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [Abstract] [Full Text] [Related]

  • 23. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
    Kurashige T, Takahashi T, Yamazaki Y, Hiji M, Izumi Y, Yamawaki T, Matsumoto M.
    Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical localization of spatacsin in α-synucleinopathies.
    Kuru S, Yoshida M, Tatsumi S, Mimuro M.
    Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408
    [Abstract] [Full Text] [Related]

  • 25. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T.
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [Abstract] [Full Text] [Related]

  • 26. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
    Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM, Trojanowski JQ.
    Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G, Jiang H, Chang M, Xie H, Hu L.
    J Neurol Sci; 2011 May 15; 304(1-2):1-8. PubMed ID: 21377170
    [Abstract] [Full Text] [Related]

  • 29. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Nov 15; 66(11):1019-26. PubMed ID: 17984683
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia.
    Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K.
    Biochem Biophys Res Commun; 2013 Jan 04; 430(1):394-9. PubMed ID: 23159615
    [Abstract] [Full Text] [Related]

  • 32. Reversible conformational change of tau2 epitope on exposure to detergent in glial cytoplasmic inclusions of multiple system atrophy.
    Shibuya K, Uchihara T, Nakamura A, Ishiyama M, Yamaoka K, Yagishita S, Iwabuchi K, Kosaka K.
    Acta Neuropathol; 2003 May 04; 105(5):508-14. PubMed ID: 12677452
    [Abstract] [Full Text] [Related]

  • 33. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
    Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H.
    Clin Neuropathol; 2000 May 04; 19(4):163-9. PubMed ID: 10919347
    [Abstract] [Full Text] [Related]

  • 34. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T.
    J Neurol; 2003 Oct 04; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [Abstract] [Full Text] [Related]

  • 35. Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism.
    McCormack A, Keating DJ, Chegeni N, Colella A, Wang JJ, Chataway T.
    Neurotox Res; 2019 May 04; 35(4):883-897. PubMed ID: 30796693
    [Abstract] [Full Text] [Related]

  • 36. Activated caspase-9 immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
    Kawamoto Y, Ayaki T, Urushitani M, Ito H, Takahashi R.
    Neurosci Lett; 2016 Aug 15; 628():207-12. PubMed ID: 27345387
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 15; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

  • 39. Glycogen synthase kinase-3beta is associated with Parkinson's disease.
    Nagao M, Hayashi H.
    Neurosci Lett; 2009 Jan 09; 449(2):103-7. PubMed ID: 19007860
    [Abstract] [Full Text] [Related]

  • 40. Glial involvement in diffuse Lewy body disease.
    Terada S, Ishizu H, Yokota O, Tsuchiya K, Nakashima H, Ishihara T, Fujita D, Uéda K, Ikeda K, Kuroda S.
    Acta Neuropathol; 2003 Feb 09; 105(2):163-9. PubMed ID: 12536227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.